Status:
COMPLETED
Clinical Utility Evidence for TissueCypher®
Lead Sponsor:
Qure Healthcare, LLC
Conditions:
Gastro-Intestinal Disorder
Barrett Esophagus
Eligibility:
All Genders
Phase:
NA
Brief Summary
Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different informati...
Eligibility Criteria
Inclusion
- Board-certified gastroenterologist or GI surgeon for at least two years
- Averages at least 20 hours per week of clinical and patient care duties over the last six months
- performs either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
- practicing in the US
- english speaking
- access to the internet
- informed and voluntarily consented to be in the study
Exclusion
- non-English speaking
- unable to access the internet
- not practicing in the US
- not averaging at least 20 hours per week of clinical or patient care duties over the last six months
- does not perform either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
- does not voluntarily consent to be in the study
Key Trial Info
Start Date :
June 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2021
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05200325
Start Date
June 6 2021
End Date
December 15 2021
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QURE Healthcare
San Francisco, California, United States, 94133